Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt ...

How easily deployable energy monitoring systems unlock efficiency, compliance and cost savings in wastewater treatment ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Expro to deliver advanced tubular running and cementing services for Woodside’s first ultra-deepwater development offshore ...